[4 October/Business Insider] A biotech company raised $25 million to finance research of psychedelics and other drugs related to depression and mental illnesses. Atai Life Scientists owned a large stake in Compass Pathways, which was backed by Peter Thiel. Atai was founded by a German entrepreneur, Christian Angermayer. He also planned to invest in research...